China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use: Report
ASİA

China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use: Report

New protein-based vaccine to be used as booster jab, local media reports

News Service AA

China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.

Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.

+

Cookies are used limited to the purposes in th e Personal Data Protection Law No.6698 and in accordance with the legislation. For detailed information, you can review our cookie policy.